Insulinoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:
Insulinoma must be differentiated from:<ref name="Abboud2008">{{cite journal|last1=Abboud|first1=Bassam|title=Occult sporadic insulinoma: Localization and surgical strategy|journal=World Journal of Gastroenterology|volume=14|issue=5|year=2008|pages=657|issn=1007-9327|doi=10.3748/wjg.14.657}}</ref>
Insulinoma must be differentiated from:<ref name="Abboud2008">{{cite journal|last1=Abboud|first1=Bassam|title=Occult sporadic insulinoma: Localization and surgical strategy|journal=World Journal of Gastroenterology|volume=14|issue=5|year=2008|pages=657|issn=1007-9327|doi=10.3748/wjg.14.657}}</ref>
*Hypoglycemia due to [[sulfonylurea]] or [[insulin]] abuse
*Hypoglycemia due to [[sulfonylurea]] or [[insulin]] abuse
*Autoimmune hypoglycemia
*Autoimmune hypoglycemia
*Factitious hypoglycemia
*Factitious hypoglycemia
*Noninsulinoma pancreatogenic hypoglycemia syndrome (NIPHS)
*Noninsulinoma pancreatogenic hypoglycemia syndrome (NIPHS)
*Familial persistent hyperinsulinemia
*Familial persistent hyperinsulinemia
*[[Nesidioblastosis]]


*[[Nesidioblastosis]]
==References==
==References==
{{Reflist|1}}
{{Reflist|1}}

Revision as of 13:46, 15 October 2015

Insulinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Insulinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Insulinoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Insulinoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Insulinoma differential diagnosis

CDC on Insulinoma differential diagnosis

Insulinoma differential diagnosis in the news

Blogs on Insulinoma differential diagnosis

Directions to Hospitals Treating Insulinoma

Risk calculators and risk factors for Insulinoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Insulinoma must be differentiated from autoimmune hypoglycemia, hypoglycemia due to sulfonylurea or insulin abuse, factitious hypoglycemia, noninsulinoma pancreatogenic hypoglycemia syndrome (NIPHS), familial persistent hyperinsulinemia, and nesidioblastosis.[1]

Differential Diagnosis

Insulinoma must be differentiated from:[1]

  • Hypoglycemia due to sulfonylurea or insulin abuse
  • Autoimmune hypoglycemia
  • Factitious hypoglycemia
  • Noninsulinoma pancreatogenic hypoglycemia syndrome (NIPHS)
  • Familial persistent hyperinsulinemia
  • Nesidioblastosis

References

  1. 1.0 1.1 Abboud, Bassam (2008). "Occult sporadic insulinoma: Localization and surgical strategy". World Journal of Gastroenterology. 14 (5): 657. doi:10.3748/wjg.14.657. ISSN 1007-9327.


Template:WikiDoc Sources